Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.390
-0.0015 (-0.383%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.304 $0.440 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $0.304 $0.532
52 weeks $0.250 $1.09

Historical Clene Inc. prices

Date Open High Low Close Volume
Aug 28, 2023 $0.712 $0.720 $0.680 $0.697 170 092
Aug 25, 2023 $0.656 $0.717 $0.627 $0.704 380 201
Aug 24, 2023 $0.680 $0.680 $0.640 $0.668 164 268
Aug 23, 2023 $0.690 $0.690 $0.650 $0.661 140 149
Aug 22, 2023 $0.699 $0.699 $0.670 $0.674 124 581
Aug 21, 2023 $0.712 $0.712 $0.663 $0.690 380 737
Aug 18, 2023 $0.699 $0.725 $0.699 $0.710 121 436
Aug 17, 2023 $0.700 $0.723 $0.695 $0.710 145 558
Aug 16, 2023 $0.740 $0.740 $0.700 $0.729 310 399
Aug 15, 2023 $0.737 $0.748 $0.710 $0.745 158 880
Aug 14, 2023 $0.695 $0.730 $0.688 $0.725 84 946
Aug 11, 2023 $0.670 $0.724 $0.670 $0.716 285 299
Aug 10, 2023 $0.698 $0.698 $0.651 $0.664 417 818
Aug 09, 2023 $0.690 $0.700 $0.661 $0.698 184 180
Aug 08, 2023 $0.661 $0.688 $0.640 $0.680 346 916
Aug 07, 2023 $0.730 $0.730 $0.660 $0.660 1 212 798
Aug 04, 2023 $0.730 $0.738 $0.713 $0.713 152 232
Aug 03, 2023 $0.750 $0.750 $0.720 $0.721 197 294
Aug 02, 2023 $0.732 $0.740 $0.715 $0.725 165 338
Aug 01, 2023 $0.752 $0.776 $0.730 $0.740 459 742
Jul 31, 2023 $0.770 $0.790 $0.750 $0.776 403 596
Jul 28, 2023 $0.750 $0.770 $0.742 $0.750 230 162
Jul 27, 2023 $0.760 $0.760 $0.731 $0.732 273 890
Jul 26, 2023 $0.750 $0.764 $0.733 $0.759 321 046
Jul 25, 2023 $0.790 $0.80 $0.740 $0.743 690 407
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT